N-terminal pro-brain natriuretic peptide; current trends in diagnostics

---

Review Article

Author Details : Haritha P Raveendran, Ajaikumar Sukumaran*, Arun R Krishnan, Jofy K Paul, D M Vasudevan

Volume : 9, Issue : 1, Year : 2024

Article Page : 3-8

https://doi.org/10.18231/j.ijirm.2024.002

Suggest article by email

Get Permission

---

Abstract

N-terminal pro-brain natriuretic peptide is the prime standard biomarker used for heart diagnosis and prognosis. Owing to the acute response and considerable half-life, the N-terminal pro-brain natriuretic peptide is the most reliable biomarker to identify a cardiac injury. N-terminal pro-brain natriuretic peptide can act as an independent risk factor for the COVID-19 infected patients, but the exact reason for raise in the level of biomarker is still unclear. Various immunological platforms like immunofluorescence, enzyme linked immunosorbent assay, lateral flow immunoassay, chemiluminescence immunoassay, stable isotope standards capture by anti-peptide antibodies assay are used to detect the N-terminal pro-brain natriuretic peptide from human blood. Chemiluminescence immunoassay lead the diagnostic platform for the determination of N-terminal pro-brain natriuretic peptide due to high stability, ultra-sensitivity, specificity, and high throughput.
 

Keywords: NT­proBNP, Chemiluminescence immunoassay, Immunofluorescence, ELISA

How to cite : Raveendran H P, Sukumaran A, Krishnan A R, Paul J K, Vasudevan D M, N-terminal pro-brain natriuretic peptide; current trends in diagnostics. IP Indian J Immunol Respir Med 2024;9(1):3-8

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.